Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Zynyz
Manufacturing
Novo's Indiana plant claims another victim in Incyte's PD-1
Incyte joins Regeneron on a growing list of drugmakers that have seen regulatory timelines delayed by compliance issues at the former Catalent site.
Angus Liu
Mar 9, 2026 10:45am
Incyte secures anal cancer nods years after FDA rejection
May 16, 2025 10:10am
JPM25: Incyte plans to turn 'a lot of cards' in 2025, CEO says
Jan 22, 2025 2:38pm
Incyte eyes upcoming launches as Jakafi's patent cliff nears
Oct 29, 2024 5:07pm
Incyte CEO views PD-1 drug Zynyz as oncology pipeline aide
Sep 14, 2024 10:30am
Incyte touts 2 trial wins for PD-1 drug Zynyz amid I-O retreat
Jul 30, 2024 11:27am
